AKT1 and renal cell carcinoma: Considering that the PI3K/Akt/mTOR signaling pathway is an important regulator of cell survival and proliferation, targeting circRNAs to inhibit PI3K/Akt/mTOR pathway may be an effective way to treat renal cell carcinoma.